Respiratory syncytial virus vaccines

mRESVIA dispersie voor injectie in een voorgevulde spuit mRNA-vaccin tegen het respiratoir syncytieel virus

Dispersie voor injectieNetherlandsAuthorisedAuthorised 22 Aug 2024

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

mResviaEuropean UnionAuthorised

MresviaCanada · 50 MCG / 0.5 ML · Dispersion · Moderna Biopharma Canada CorporationSame brand
mResviaEuropean Union · Moderna Biotech Spain, S.L.Same brand
MresviaItaly · Dispersione per preparazione iniettabile · Moderna Biotech Spain, S.L.Same brand
mRESVIA Dispersion for Injection in Pre-Filled Syringe 50mcg/0.5mlSingapore · 0.050mg/0.5ml dose · injection, solution · Moderna Biotech Singapore Pte. LTD.Same brand
mresviaUnited States · 50UG/.5ML · For Injection · ModernaTX, Inc.Same brand

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Respiratory syncytial virus vaccines

mRESVIA dispersie voor injectie in een voorgevulde spuit mRNA-vaccin tegen het respiratoir syncytieel virus

Dispersie voor injectieNetherlandsAuthorisedAuthorised 22 Aug 2024

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Authorised centrally in the EU

This national listing belongs to a medicine the European Commission authorised for the whole EU.

mResviaEuropean UnionAuthorised

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Abrysvo

Italy · Polvere e solvente per soluzione iniettabile · Pfizer Europe Ma Eeig

ArexvyItaly · Polvere e sospensione per sospensione iniettabile · Glaxosmithkline Biologicals S.A.

AREXVY Powder and Suspension for Suspension for Injection 120mcg/0.5mLSingapore · 120mcg/0.5mL · injection, powder, lyophilized, for liposomal suspension · Glaxosmithkline Pte LTD

AbrysvoUnited States · 120UG · Injection · Pfizer Inc.

ArexvyCanada · 120 MCG / 0.5 ML · Powder For Suspension · Glaxosmithkline INC

AbrysvoEuropean Union · Pfizer Europe MA EEIG

ArexvyEuropean Union · GlaxoSmithKline Biologicals S.A.

Arexvy, cjepivo protiv respiratornog sincicijskog virusa (RSV) (rekombinantno, adjuvantirano)Croatia

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

College ter Beoordeling van Geneesmiddelen

College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.

Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim · Added 8 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Respiratory syncytial virus vaccines
Dosage form: Dispersie voor injectie
Route: Intramusculair gebruik
Register: Netherlands (CBG-MEB)
Status: Authorised
Status in the register: Ingeschreven
Authorised: 22 Aug 2024
Registration: EU/1/24/1849
Marketing authorisation holder: Moderna Biotech Spain S.L.
ATC code: J07BX05
Group: Anti-infectives for systemic use
Procedure: EU centralised
Supply: Uitsluitend recept
EMA product number: EMEA/H/C/006278
EU number: EU/1/24/1849